Rakesh Jhunjhunwala Looking For IRDA nod For Star Health Insurance Investment
Mar 11, 2019 | 12:06 PM IST
Mar 11, 2019 | 12:06 PM IST
The big bull of Indian stock exchange, Rakesh Jhunjhunwala who is thought for his interesting finance pattern and his unerring foresight for finance in business has himself given clarification relating to the rumour that his association is reluctant to buy stake in Star health insurance.
Jhunjhunwala recently said in an interview said that the corporate is in reality awaiting approval from Insurance Regulatory and Development Authority (IRDA). Giving rest to the sooner speculation of birth control of the deal within which he wished to shop for thirty-fifth stake in Star insurance.
Jhunjhunwala is believed to be trying to shop for 35th stake within the insurer for an investment of 2,250-2500 large integer.
According to some media reports, Safecrop Holdings, an association of WestBridge AIF, la Rakesh Jhunjhunwaand Madison Capital, has signed definitive agreements with the stakeholders of Star Health & Allied Insurance firms for the acquisition regarding 35th stock in the countrys largest independent health insurance underwriter.
Rakesh Jhunjhunwaan is an Indian billionaire capitalist and trader known his infallible foresight in stock market business. He manages his own portfolio as a partner in his asset management firm named- Rare Enterprises and is also better-known Pied Piper of Indian bourses.
Now Follow Rakesh Jhunjhunwala's Latest Portfolio, Holdings And Track his Picks With Us. To Know His Latest Stock Picks Read Rakesh Jhunjhunwala's Latest Portfolio, Holdings, And Picks 2019
At Niveza India Pvt Ltd., we all come to work everyday to take the challenges of stock market head on and to change people's perception that stock market investment is like a gamble. Over the years, we have built our profile as a company which has brought optimum value to our subscribers through our well-researched stock recommendations.... More>>
Disclaimer: Niveza does not guarantee the accuracy or completeness of information on the site, nor does Niveza assume any liability for any loss that may result from reliance upon any such information or recommendations. Information and recommendations on the site are for general information only. Nothing contained herein is an offer to sell nor solicitation to buy any securities.